Effect of a heart failure program on hospitalization frequency and exercise tolerance.

BACKGROUND Most patients with heart failure are currently managed by physicians with little specific expertise in heart failure. This management system has been associated with evidence of suboptimal care, such as high rates of hospital readmission and underuse of ACE inhibitors. The current study was undertaken to determine whether hospitalization rates and functional outcomes are improved when patients are managed by physicians with special expertise in heart failure working in a dedicated heart failure program. METHODS AND RESULTS All patients with heart failure referred to the Vanderbilt Heart Failure and Heart Transplantation Program between July 1994 and June 1995 were identified. Annual hospitalization rates, medications, and peak exercise capacity before and after referral were compared in patients followed for >30 days. A total of 187 patients were referred during the index time period, of whom 134 (72%) were followed for >30 days. During the year before referral, 94% of the patients were hospitalized (210 cardiovascular hospitalizations) versus 44% of the patients during the year after referral (104 hospitalizations) (53% reduction) (P<.01). Hospitalizations for heart failure decreased from 164 to 60 for all patients regardless of follow-up duration and decreased from 97 to 30 (69% reduction) for patients followed at least 1 year after referral. Eighty-eight of the patients were able to exercise at the time of referral. Peak exercise VO2 in this group increased from 12.8+/-4.7 to 15.7+/-4.8 mL x min(-1) x kg(-1) (P<.01) by 6 months after referral. Loop diuretic doses were on averaged doubled during the first 6 months after referral. CONCLUSIONS These findings suggest that patients with heart failure have fewer hospitalizations for heart failure and are significantly more functional when managed by heart failure specialists working in a dedicated heart failure program rather than by physicians with limited expertise in heart failure.

[1]  C. Lang,et al.  Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[3]  R N Pierson,et al.  Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. , 1996, Circulation.

[4]  J. Wilson,et al.  Circulatory status and response to cardiac rehabilitation in patients with heart failure. , 1996, Circulation.

[5]  M. Weinberger,et al.  Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. , 1996, The New England journal of medicine.

[6]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[7]  R. Carney,et al.  A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.

[8]  P. Singh.  Managing chronic congestive heart failure in the home. , 1995, Home healthcare nurse.

[9]  G. Fonarow,et al.  981-46 Impact of a Comprehensive Management Program on the Hospitalization Rate for Patients with Advanced Heart Failure , 1995 .

[10]  G. Fonarow,et al.  Improvement in exercise capacity of candidates awaiting heart transplantation. , 1995, Journal of the American College of Cardiology.

[11]  B J McNeil,et al.  Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. , 1994, The New England journal of medicine.

[12]  M. Bristow,et al.  Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  S. Yusuf,et al.  Natural history and patterns of current practice in heart failure , 1993 .

[14]  W. Stevenson,et al.  Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[15]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[16]  J. Cohn,et al.  Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.

[17]  P E Leaverton,et al.  Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.

[18]  J. Wasson,et al.  Telephone care as a substitute for routine clinic follow-up. , 1992, JAMA.

[19]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[20]  Stevenson Lw.  Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. , 1991 .

[21]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[22]  L. Stevenson,et al.  Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. , 1989, The American journal of cardiology.

[23]  T. Rector.  Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire , 1987 .

[24]  R. Jones,et al.  Use of maximal bicycle exercise testing with respiratory gas analysis to assess exercise performance in patients with congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy. , 1986, The American journal of cardiology.

[25]  W L Beaver,et al.  Anaerobic threshold and respiratory gas exchange during exercise. , 1973, Journal of applied physiology.